secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2025-10-02T23:59:59+00:00
Accession:  0001773751-25-000331
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers COO Nader Kabbani transitions to advisory role; Mike Chi promoted to COO
--------------------------------------------------------------------------------

- Nader Kabbani steps into advisory role effective Nov 2, 2025, through July 2026.
- Mike Chi, formerly Chief Commercial Officer, appointed COO effective Nov 2, 2025.
- Chi will oversee operations, marketing, product, and commercial functions in consolidated role.
- Chi joined Hims & Hers in April 2021; prior roles include CMO at Zola and VP at INTERMIX.
- Compensation Committee will review potential adjustments to Chi's pay for his expanded responsibilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375125000331/0001773751-25-000331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375125000331/hims-20250928.htm
  HTML page:      https://secwatch.observer/filing/0001773751-25-000331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer